These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Anorexigen-induced pulmonary hypertension and the serotonin (5-HT) hypothesis: lessons for the future in pathogenesis. Eddahibi S; Adnot S Respir Res; 2002; 3(1):9. PubMed ID: 11806844 [TBL] [Abstract][Full Text] [Related]
9. [Anorectics and pulmonary hypertension]. Bíbová J; Hampl V Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744 [TBL] [Abstract][Full Text] [Related]
10. Anorectic drugs and pulmonary hypertension from the bedside to the bench. Michelakis ED; Weir EK Am J Med Sci; 2001 Apr; 321(4):292-9. PubMed ID: 11307870 [TBL] [Abstract][Full Text] [Related]
11. Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension. Archer SL; Djaballah K; Humbert M; Weir KE; Fartoukh M; Dall'ava-Santucci J; Mercier JC; Simonneau G; Dinh-Xuan AT Am J Respir Crit Care Med; 1998 Oct; 158(4):1061-7. PubMed ID: 9769261 [TBL] [Abstract][Full Text] [Related]
12. Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity. Anchors M Arch Intern Med; 1997 Jun; 157(11):1270. PubMed ID: 9183245 [No Abstract] [Full Text] [Related]
13. Fen-phen manufacturers, not physicians, are liable. Allen S; Henderson J Tex Med; 2000 May; 96(5):62-4. PubMed ID: 10843016 [No Abstract] [Full Text] [Related]
14. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants]. Goldstein SE; Levy Y; Shoenfeld Y Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459 [TBL] [Abstract][Full Text] [Related]
15. Too late, again? Jones NL Can Respir J; 2001; 8(3):127-8. PubMed ID: 11420587 [No Abstract] [Full Text] [Related]
16. Synergistic interactions between fenfluramine and phentermine. Wellman PJ; Maher TJ Int J Obes Relat Metab Disord; 1999 Jul; 23(7):723-32. PubMed ID: 10454106 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension as a result of drug therapy. Higenbottam T; Laude L; Emery C; Essener M Clin Chest Med; 2004 Mar; 25(1):123-31. PubMed ID: 15062604 [TBL] [Abstract][Full Text] [Related]
19. Serotonin 5-HT(2B) receptor loss of function mutation in a patient with fenfluramine-associated primary pulmonary hypertension. Blanpain C; Le Poul E; Parma J; Knoop C; Detheux M; Parmentier M; Vassart G; Abramowicz MJ Cardiovasc Res; 2003 Dec; 60(3):518-28. PubMed ID: 14659797 [TBL] [Abstract][Full Text] [Related]
20. The age-adjusted mortality rate from primary pulmonary hypertension, in age range 20 to 54 years, did not increase during the years of peak "phen/fen" use. Rothman RB Chest; 2000 Nov; 118(5):1516-7. PubMed ID: 11083718 [No Abstract] [Full Text] [Related] [Next] [New Search]